liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mitochondrial proteins in neuronal degeneration
Department of Neuroscience, Uppsala University, Biomedical Centre, Uppsala, Sweden; Minerva Research Institute, Helsinki, Finland.
Institute of Biomedicine/Biochemistry, University of Helsinki, Helsinki, Finland.ORCID iD: 0000-0001-5111-1374
Department of Neuroscience, Uppsala University, Biomedical Centre, Uppsala, Sweden.ORCID iD: 0000-0002-1837-5930
2004 (English)In: Biochemical and Biophysical Research Communications - BBRC, ISSN 0006-291X, E-ISSN 1090-2104, Vol. 321, no 4, p. 753-758Article in journal, Editorial material (Other academic) Published
Abstract [en]

In this review. we highlight recent findings about the role of some mitochondrial proteins in neurological diseases. Studies in mice gene-deleted for Omi/HtrA2 and AIF showed the involvement of these mitochondrial proteins in, selective cell degeneration in the spinal cord and brain. In humans, mutations in the mitochondrial protein, Paraplegin, cause an autosomal form of hereditary spastic paraplegia with an enhanced sensitivity to oxidative stress. Reactive oxygen species and decreased respiratory chain activity in mitochondria also contribute to common neurological diseases. The mitochondrial uncoupling protein, Ucp-2, was found to be neuroprotective in experimental stroke and brain trauma. Recent proteomic and profiling studies have revealed the existence of additional mitochondrial proteins with unknown functions. The elucidation of the physiological functions of mitochondrial proteins may lead to new insights into the role of these organelles in cell degeneration and to identification of novel drug targets for the prevention and treatment of different diseases. (C) 2004 Elsevier Inc. All rights reserved.

Place, publisher, year, edition, pages
Uppsala Univ, Ctr Biomed, Dept Neurosci, S-75123 Uppsala, Sweden. Minerva Res Inst, Helsinki 00290, Finland. Univ Helsinki, Inst Biomed Biochem, Helsinki, Finland.: ACADEMIC PRESS INC ELSEVIER SCIENCE , 2004. Vol. 321, no 4, p. 753-758
Keywords [en]
mitochondria, neurological disease, paraplegin, omi, AIF, Ucp-2
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-167990DOI: 10.1016/j.bbrc.2004.06.138ISI: 000223381100001PubMedID: 15358091Scopus ID: 2-s2.0-4043175548OAI: oai:DiVA.org:liu-167990DiVA, id: diva2:1457461
Available from: 2020-08-11 Created: 2020-08-11 Last updated: 2025-04-04Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Korhonen, Laura

Search in DiVA

By author/editor
Eriksson, OveKorhonen, Laura
In the same journal
Biochemical and Biophysical Research Communications - BBRC
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 21 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf